Elequin Capital LP Intercept Pharmaceuticals, Inc. Transaction History

Elequin Capital LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$12.21 - $19.7 $9,938 - $16,035	-814 Reduced 90.44%	86 $1,000
Q2 2022 Aug 11, 2022	BUY	$11.23 - $19.59 $258 - $450	23 Added 2.62%	900 $12,000
Q1 2022 May 16, 2022	BUY	$13.37 - $17.79 $11,725 - $15,601	877 New	877 $14,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Elequin Capital LP, based on Form 13F filings with the SEC.

Stay updated on Elequin Capital LP with notifications on news.